Banque Pictet & Cie’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,120
Closed -$232K 324
2016
Q3
$232K Hold
2,120
0.01% 308
2016
Q2
$256K Hold
2,120
0.01% 308
2016
Q1
$241K Hold
2,120
0.01% 304
2015
Q4
$228K Hold
2,120
0.01% 298
2015
Q3
$214K Sell
2,120
-9,243
-81% -$1.01M 0.01% 339
2015
Q2
$1.31M Sell
11,363
-3,414
-23% -$414K 0.1% 125
2015
Q1
$1.51M Sell
14,777
-826
-5% -$88K 0.04% 211
2014
Q4
$1.9M Buy
15,603
+3,163
+25% +$415K 0.05% 199
2014
Q3
$1.84M Sell
12,440
-1,570
-11% -$242K 0.05% 192
2014
Q2
$2.34M Sell
14,010
-150
-1% -$26.7K 0.06% 177
2014
Q1
$2.81M Sell
14,160
-282
-2% -$53.2K 0.08% 157
2013
Q4
$2.89M Buy
+14,442
New +$2.69M 0.09% 154

Other funds holding CLB

Banque Pictet & Cie's CLB Position: Q4 2016 in Review

Banque Pictet & Cie sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 2,120 shares — an estimated $232K sold.

Banque Pictet & Cie first reported a position in CLB in Q4 2013 and held it in 12 quarters. The position peaked at $2.89M in Q4 2013. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

  • Banque Pictet & Cie reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
  • Banque Pictet & Cie sold 2,120 Core Laboratories shares in Q4 2016, an estimated $232K.
  • Banque Pictet & Cie first reported a position in Core Laboratories in Q4 2013 and held it in 12 quarters.
  • Banque Pictet & Cie's Core Laboratories position peaked at $2.89M in Q4 2013.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on Banque Pictet & Cie's 13F filing for Q4 2016, filed 6 Feb 2017.